Abstract:Mass spectrometry imaging (MSI) provides insight into the molecular distribution of a broad range of compounds and, therefore, is frequently applied in the pharmaceutical industry. Pharmacokinetic and toxicological studies deploy MSI to localize potential drugs and their metabolites in biological tissues but currently require other analytical tools to quantify these pharmaceutical compounds in the same tissues. Quantitative mass spectrometry imaging (Q-MSI) is a field with challenges due to the high biological variability in samples combined with the limited sample cleanup and separation strategies available prior to MSI. In consequence, more selectivity in MSI instruments is required. This can be provided by multiple reaction monitoring (MRM) which uses specific precursor ion-product ion transitions. This targeted approach is in particular suitable for pharmaceutical compounds because their molecular identity is known prior to analysis. In this work, we compared different analytical platforms to assess the performance of MRM detection compared to other MS instruments/MS modes used in a Q-MSI workflow for two drug candidates (A and B). Limit of detection (LOD), linearity, and precision and accuracy of high and low quality control (QC) samples were compared between MS instruments/modes. MRM mode on a triple quadrupole mass spectrometer (QqQ) provided the best overall performance with the following results for compounds A and B: LOD 35.5 and 2.5 μg/g tissue, R2 0.97 and 0.98 linearity, relative standard deviation QC <13.6%, and 97-112% accuracy. Other MS modes resulted in LOD 6.7-569.4 and 2.6-119.1 μg/g tissue, R2 0.86-0.98 and 0.86-0.98 linearity, relative standard deviation QC < 19.4 and < 37.5%, and 70-356% and 64-398% accuracy for drug candidates A and B, respectively. In addition, we propose an optimized 3D printed mimetic tissue model to increase the overall analytical throughput of our approach for large animal studies. The MRM imaging platform was applied as proof-of-principle for quantitative detection of drug candidates A and B in four dog livers and compared to LC-MS. The Q-MSI concentrations differed <3.5 times with the concentrations observed by LC-MS. Our presented MRM-based Q-MSI approach provides a more selective and high-throughput analytical platform due to MRM specificity combined with an optimized 3D printed mimetic tissue model.

Quantitative Mass Spectrometry Imaging: Therapeutics & Biomolecules

Quantitative mass spectrometry imaging (qMSI): A tutorial

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review

Recent advancement and applications of mass spectrometry imaging

A critical evaluation of the current state-of-the-art in quantitative imaging mass spectrometry

Emerging Technologies in Mass Spectrometry Imaging

From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging

Mass Spectrometry Imaging Techniques: Non-Ambient and Ambient Ionization Approaches

Development of mass spectrometry imaging techniques and its latest applications

Postionization Mass Spectrometry Imaging: Past, Present, and Future

Advances in MALDI Mass Spectrometry Imaging Single Cell and Tissues

High-throughput mass spectrometry imaging of biological systems: Current approaches and future directions

Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison

Mass Spectrometry Imaging for Biomedical Applications

Future technology insight: mass spectrometry imaging as a tool in drug research and development

Targeted Desorption Electrospray Ionization Mass Spectrometry Imaging for Drug Distribution, Toxicity, and Tissue Classification Studies

Spatially resolved absolute quantitation in thin tissue by mass spectrometry

Updated Progress on Mass Spectrometry Imaging and its Application in Cancer Treatment and Drug Discovery

Mass spectrometry imaging methods for visualizing tumor heterogeneity

Targeted Drug and Metabolite Imaging: Desorption Electrospray Ionization Combined with Triple Quadrupole Mass Spectrometry